Video Experimental Relacionado
Updated: Jun 23, 2026
09:53
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.6K
DAGFormer: Un enfoque de adaptación de dominio basado en grafos para la predicción de la respuesta a fármacos contra
Fen Yan1, ZhiHua Du1, Yu-An Huang2,3
1College of Computer Science and Software Engineering, Shenzhen University, Shenzhen, China.
PLoS computational biology
|December 19, 2025
Resumen
DAGFormer integra datos de secuenciación de ARN a granel y de células únicas para predecir las respuestas a los fármacos contra el cáncer, mejorando la comprensión de la heterogeneidad tumoral y los mecanismos de resistencia. Este novedoso marco de adaptación de dominio basado en grafos mejora la precisión en las predicciones de terapias contra el cáncer personalizadas.
Sus antecedentes:
- La predicción precisa de la respuesta a fármacos en células únicas es crucial para comprender la heterogeneidad tumoral y mejorar la terapia contra el cáncer.
- Los métodos actuales que integran datos de secuenciación de ARN a granel y de células únicas (ARNseq) enfrentan desafíos como efectos de lotes y un rendimiento limitado.
- Los enfoques existentes a menudo descuidan las interacciones intercelulares, tratando las células como entidades aisladas.
Conclusiones:
- DAGFormer ofrece un enfoque potente para la predicción de la respuesta a fármacos en células únicas mediante la integración de datos de secuenciación multimodales.
- El marco mejora la comprensión de la heterogeneidad tumoral y las interacciones intercelulares en el cáncer.
- DAGFormer tiene un potencial significativo para avanzar en la terapia contra el cáncer personalizada y el descubrimiento de fármacos.
Palabras clave:
DAGFormeradaptación de dominiocélulas únicaspredicción de respuesta a fármacosARNseqbiología computacionalgenómicainvestigación del cáncerMás Videos Relacionados
Videos de Conceptos Relacionados
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...